Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML)

T Kindler, F Breitenbuecher, S Kasper, E Estey, F Giles… - Blood, 2005 - ashpublications.org
Fms-like tyrosine kinase 3 (FLT3) receptor mutations as internal tandem duplication (ITD) or
within the kinase domain are detected in up to 35% of patients with acute myeloid leukemia …

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth

IM Harwerth, W Wels, J Schlegel, M Müller… - British journal of …, 1993 - nature.com
Four monoclonal antibodies (MAbs) specific for the extracellular domain of the human erbB-
2/HER2 protein (FRP5, FSP16, FWP51 and FSP77) have been isolated (Harwerth et al., J …

Midostaurin in acute myeloid leukemia: an evidence-based review and patient selection

HA Abbas, M Alfayez, T Kadia… - Cancer management …, 2019 - Taylor & Francis
Abstract Fms-related-tyrosine kinase 3 (FLT3) mutations occur in approximately a third of
acute myeloid leukemia (AML) patients and confer an adverse prognosis. Numerous studies …

Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization

AL Vandenbogaerde, EM Delaey… - Photochemistry and …, 1998 - Wiley Online Library
The toxicity on three human tumor cell lines (A431, HeLa and MCF7) of five
phenanthroperylenequinones (hypericin and derivatives) and two perylenequinones …

A survey of indolo [2, 3-a] carbazole alkaloids and related natural products

GW Gribble, SJ Berthel - Studies in Natural Products Chemistry, 1993 - Elsevier
6 indolo [2, 3-a] carbazole (1) 1H-indolo [2, 3-a] pyrrolo [3, 4-c] carbazole (2) Since the
synthetic approaches to indolo [2, 3-a] carbazoles were reviewed in volume 1 of this series …

UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: a new generation of anti-cancer agents for the new century?

S Akinaga, K Sugiyama, T Akiyama - Anti-cancer drug design, 2000 - ingentaconnect.com
UCN-01 (7-hydroxystaurosporine) is a protein kinase inhibitor which is under development
as an anti-cancer agent in the USA and Japan. Although UCN-01 was originally isolated …

Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen

WT Couldwell, MH Weiss, CM DeGiorgio… - …, 1993 - journals.lww.com
Abstract PREVIOUS WORK HAS demonstrated the importance of the Protein Kinase C
(PKC) signal transduction system in regulating the growth rate of malignant gliomas in vitro …

Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine

JS Strobl, KL Kirkwood, TK Lantz, MA Lewine… - Cancer research, 1990 - AACR
Permanent cell culture lines derived from human breast cancer tissue are important
experimental models in the study of human breast cancer cell proliferation. In the present …

Protein kinase C: is its pivotal role in cellular activation over-stated?

SE Wilkinson, TJ Hallam - Trends in pharmacological sciences, 1994 - cell.com
Evidence has emerged over the past decade to suggest thnt protein kinnse C (PM3 is a
widespread family of kirrnses responsible for mnny diverse nrzd crztical cellular functions …

IκB kinases α and β show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin

GW Peet, J Li - Journal of Biological Chemistry, 1999 - ASBMB
Activation of transcription factor NF-κB is regulated by phosphorylation and subsequent
degradation of its inhibitory subunit IκB. The signal-induced phosphorylation of IκB involves …